We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
TIGS and the Avestagenome Project® partner to advance research in Rare Genetic Disorders
The Avestagenome Project® International Pvt. Ltd. (AGENOME) & Avesthagen Limited, in partnership... read more
Talk by Dr. Farah Ishtiaq at ALARM 2022
Dr. Farah Ishtiaq, Principal Scientist at TIGS spoke on wastewater-based epidemiology for... read more
Dr. Farah’s Presentation at London
On May 16th Farah Ishtiaq, Principal Scientist, TIGS along with Dr. Angela... read more
TIGS and DBT – Centre for DNA Fingerprinting and Diagnostics (CDFD) sign MoU to work on Rare Genetic Disorders
The prevalence of rare genetic disorders (RGDs) in India — home to... read more
Healthcare to agriculture: How genome revolution could be game changer
One of the biggest developments in science has been the precise deciphering... read more
Talk by Dr. Farah Ishtiaq on Genomic Surveillance to track diseases in wastewater
Dr. Farah Ishtiaq, Principal Scientist at TIGS, gave a talk on the... read more
Discarded storage containers may be aggravating Bengaluru dengue outbreaks
In this latest piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS in... read more
Podcast on COVID – 19 vaccines
Podcast - COVID-19 Vaccine: Why Has the Centre Termed Additional Doses as... read more
Latest publication: One Health Index Calculator for India
We are excited to share our recent publication where researchers have developed... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more

